| Expenses by Nature |
The Company discloses its statement of income
by function and thus presents below the details by nature:
| Schedule of expenses |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
12.31.24 |
|
12.31.23 |
|
12.31.22 |
| Costs of sales |
|
|
|
|
|
|
|
|
|
| Raw materials and supplies |
|
|
|
|
(32,717,134) |
|
(33,474,310) |
|
(34,930,469) |
| Salaries and employees benefits |
|
|
|
|
(6,248,972) |
|
(5,161,849) |
|
(4,690,868) |
| Depreciation |
|
|
|
|
(2,705,436) |
|
(2,448,711) |
|
(2,319,631) |
| Amortization |
|
|
|
|
(213,578) |
|
(210,288) |
|
(185,852) |
| Other |
|
|
|
|
(3,658,102) |
|
(3,486,581) |
|
(3,545,556) |
| Cost of sales |
|
|
|
|
(45,543,222) |
|
(44,781,739) |
|
(45,672,376) |
| |
|
|
|
|
|
|
|
|
|
| Operating income (expenses): |
|
|
|
|
|
|
|
|
|
| Sales |
|
|
|
|
|
|
|
|
|
| Indirect and direct logistics expenses |
|
|
|
|
(3,775,463) |
|
(3,691,443) |
|
(3,415,266) |
| Marketing |
|
|
|
|
(963,537) |
|
(802,754) |
|
(801,194) |
| Salaries and employees benefits |
|
|
|
|
(2,000,136) |
|
(1,697,652) |
|
(1,548,788) |
| Depreciation |
|
|
|
|
(443,188) |
|
(382,267) |
|
(341,009) |
| Amortization |
|
|
|
|
(92,898) |
|
(82,911) |
|
(68,317) |
| Other |
|
|
|
|
(807,440) |
|
(797,136) |
|
(892,574) |
| Sales expenses |
|
|
|
|
(8,082,662) |
|
(7,454,163) |
|
(7,067,148) |
| |
|
|
|
|
|
|
|
|
|
| Administrative expenses |
|
|
|
|
|
|
|
|
|
| Salaries and employees benefits |
|
|
|
|
(531,780) |
|
(366,142) |
|
(319,187) |
| Fees |
|
|
|
|
(129,348) |
|
(65,417) |
|
(46,602) |
| Depreciation |
|
|
|
|
(47,308) |
|
(41,710) |
|
(33,896) |
| Amortization |
|
|
|
|
(22,305) |
|
(58,894) |
|
(43,000) |
| Other |
|
|
|
|
(222,318) |
|
(225,673) |
|
(202,142) |
| Administrative expenses |
|
|
|
|
(953,059) |
|
(757,836) |
|
(644,827) |
| |
|
|
|
|
|
|
|
|
|
| Impairment loss on trade receivables |
|
|
|
|
(28,817) |
|
(32,809) |
|
(12,772) |
| |
|
|
|
|
|
|
|
|
|
| Other operating income (expenses), net |
|
|
|
|
|
|
|
|
|
| Recovery of expenses |
|
|
|
|
62,495 |
|
52,600 |
|
128,895 |
| Civil and tax contingencies (assets or liabilities) |
|
|
|
(124,680) |
|
146,423 |
|
(102,539) |
| Results with sale and disposal of fixed assets and investments |
|
|
|
163,983 |
|
63,229 |
|
(3,985) |
| Expenses with investigations |
|
|
|
|
- |
|
(1,112) |
|
(588,774) |
| Other |
|
|
|
|
(19,015) |
|
(10,628) |
|
21,133 |
| Other operating income (expenses),
net |
|
|
|
|
82,783 |
|
250,512 |
|
(545,270) |
The Company incurred in expenses with internal
research and development of new products of R$66,068 for the year ended December 31, 2024, (R$48,041 for the year ended December 31,
2023).
|